Acer therapeutics announces topline results from its bioequivalence trial of acer-001 compared to buphenyl® under fed conditions

Targeting a pre-nda meeting with fda in q2 2021 targeting a pre-nda meeting with fda in q2 2021
ACER Ratings Summary
ACER Quant Ranking